Obesity is thought to exert detrimental effects on the cardiovascular (CV) system. However, this relationship is impacted by the co-occurrence of CV risk factors, type 2 diabetes (T2DM) and overt disease. We examined the relationships between obesity, assessed by body mass index (BMI) and waist circumference (WC), and CV function in 102 subjects without overt CV disease. We hypothesized that obesity would be independently predictive of CV remodeling and functional differences, especially at peak exercise. METHODS: Brachial (bSBP) and central (cSBP) systolic pressure, carotid-to-femoral pulse wave velocity (PWVcf) augmentation index (AGI; by SphygmoCor), and carotid remodeling (B-mode ultrasound) were examined at rest. Further, peak exercise cardiac imaging (Doppler ultrasound) was performed to measure the coupling between the heart and arterial system. RESULTS: In backward elimination regression models, accounting for CV risk factors, neither BMI nor WC were predictors of carotid thickness or PWVcf; rather age, triglycerides and hypertension were the main determinants. However, BMI and WC predicted carotid cross-sectional area and lumen diameter. When examining the relationship between body size and SBP, BMI (β = 0.32) and WC (β = 0.25) were predictors of bSBP (P o 0.05), whereas, BMI was the only predictor of cSBP (β = 0.22, P o0.05) indicating a differential relationship between cSBP, bSBP and body size. Further, BMI (β = − 0.26) and WC (β = − 0.27) were independent predictors of AGI (P o0.05). As for resting cardiac diastolic function, WC seemed to be a better predictor than BMI. However, both BMI and WC were inversely and independently related to arterial-elastance (net arterial load) and end-systolic elastance (cardiac contractility) at rest and peak exercise. CONCLUSION: These findings illustrate that obesity, without T2DM and overt CV disease, and after accounting for CV risk factors, is susceptible to pathophysiological adaptations that may predispose individuals to an increased risk of CV events.
INTRODUCTION
Obesity represents a disease of epidemic proportions with 36% of adults in United States presenting with obesity. 1 The health consequences with obesity are numerous with an increased risk of cardiovascular (CV) events. 2 Impairments in CV function have been reported with obesity. [3] [4] [5] [6] [7] [8] While these studies provide important information on the pathophysiological associations with obesity, the obese populations examined tended to present with type 2 diabetes mellitus (T2DM) and overt CV disease. Further, often the co-occurrence of CV risk factors was not taken into account when examining the CV associations with obesity. Thus, the reported associations may reflect the contribution of comorbidities to the CV dysfunction. Identification of the early manifestations of CV dysfunction before the development of T2DM and overt CV disease may represent a critical window for interventions aimed at preventing the development of chronic CV adaptations that expose obese subjects to various CV pathologies, including heart failure. 9 The interplay between the arterial system and the left ventricle (LV), known as arterial-ventricular coupling, has an important role in CV performance, 10 and is a predictor of CV mortality. 11 Indeed, a mismatch in arterial-ventricular coupling has been implicated as a pathway leading to heart failure. 12 It is therefore important to understand the interplay between the arterial system and LV to fully comprehend the impact of obesity on CV function and its associated risk with CV events. To date, most of the obesity-related CV associations have been limited to resting measures. Examining CV associations during exercise would provide further pathophysiological insights into the effects of obesity.
The aim of this study was to examine the relationship between obesity and measurements of LV and arterial structure/function at rest and peak exercise, independent of CV risk factors, in a population free of T2DM and overt CV disease. We hypothesized that obesity will be independently predictive of CV remodeling and functional differences, especially at peak exercise. However, common methods for the quantification of obesity, namely body mass index (BMI) and waist circumference (WC) reflect different aspects of obesity. BMI is regarded as a general measure of obesity that has poor sensitivity for calculating percentage body fat (%BF); 13 whereas, WC is highly correlated with intraabdominal fat volumes 14 and predicts increased mortality beyond that accounted for by BMI. 15 As such, BMI may underrepresent the epidemic 16, 17 and the physiological associations to the CV system. Therefore, the second aim of the study was to compare relationship between the various measures of obesity (that is, BMI, WC and %BF) and CV function. We expected that the WC would be better suited for the assessment of CV dysfunction compared with BMI and %BF.
MATERIALS AND METHODS

Study subjects
Subjects were recruited from the Morgantown, WV area in response to advertisements for CV assessments. The total study sample comprised 102 subjects (33 men and 69 women) between 22-70 years, who were free from T2DM and overt CV disease as determined by a detailed medical history, physical examination and a normal resting electrocardiogram. Further, none of the subjects were current or former smokers. Exclusion criteria included pulmonary disease, angina, atrial fibrillation, aortic stenosis, anemia, myocardial infarction, stroke or coronary revascularization as assessed by a detailed medical history and physical examination, including the examination of a carotid ultrasound. Subjects who participated in regular exercise (430 min per day, 3 times per week) were excluded to ensure similar physical activity levels between subjects. All subjects provided written informed consent to participate that was approved by WVU Institutional Review Board.
Study design
CV assessments were performed between 0700-1000 hours, in a quiet, temperature-controlled room, after a 12-h fast and abstinence from alcohol, caffeine and vitamins. CV medications were withheld 24 h before assessments. After 15 min of quiet rest, subjects underwent resting supine noninvasive assessments of CV structure and function. Once supine assessments were completed, subjects performed a maximal exercise stress test to measure peak CV function.
Body anthropometry. Height and weight, from which BMI (weight/ height 2 ), were measured using standard laboratory procedures. Fat distribution was assessed by measuring the WC at the site of the smallest circumference between the rib cage and the ileac crest, with the subjects in standing position. Percentage of body fat (%BF) was calculated from body volume by the BodPod (Life measurement, Concord, CA, USA). Subjects wore tightly fitting bathing suits and a swim cap during the volume measurements in the BodPod. Of note, %BF was available on 84 of the 102 subjects.
Metabolic indices. Blood sampling was performed in the morning after a 12-h fast. Blood was drawn locally and processed at the central laboratory of WVU Hospital in Morgantown, WV, USA. High-density lipoprotein (HDL) cholesterol, triglycerides (Tg), glucose and insulin were determined using standard clinical laboratory techniques. Homeostasis model assessment of insulin resistance (HOMA-IR) was estimated with the following formula: insulin resistance = fasting plasma insulin (μU ml − 1 ) × fasting plasma glucose (mmol l − 1 )/22.5.
CV measurements
Blood pressure and pulse wave analysis: Automated (Critikon Dinamap Compact BP monitor, GE Medical Systems, Milwaukee, WI, USA) brachial systolic (bSBP) and diastolic (bDBP) BP were measured from which pulse pressure (bPP) was calculated (bSBP − bDBP). As previously described in detail, 18 pulse wave analysis was performed noninvasively on the radial artery (SphygmoCor system, AtCor Medical, Sydney, Australia). Central BP (that is, cSBP and cPP) were estimated using a generalized transfer function and customized software (SphygmoCor system). Central augmented pressure (AP) was defined as the difference between cSBP and the pressure at the forward wave peak. Central augmentation index (AGI) was calculated AP/cPP × 100 and adjusted to a 'standard HR' of 75 beats per min (AGI@75). Arterial geometry and stiffness: In the supine position, ultrasound (GE Vivid i) two-dimensional (2D) images of the right common carotid artery were obtained 1-2 cm proximal to the carotid bifurcation to measure maximal lumen diameter (CDd), and intima-medial thickness (cIMT). Common carotid artery cross-sectional area was calculated as cCSA = [(CDd/2) 2 × π-(CDd/2-cIMT) 2 × π]. Carotid-to-femoral pulse wave velocity (PWVcf; central arterial stiffness) was measured by applanation tonometry (AtCor Medical). ECG-gated waveforms were sequentially recorded. Aortic distance was calculated as the difference in the distances from the carotid to the suprasternal notch and from the suprasternal notch to the femoral artery. Time delay was calculated using a foot-of-the-wave method.
Exercise capacity: Subjects exercised to exhaustion on a modified monarch bike, which allowed the subject to exercise in an upright position while assisting the sonographer with the acquisition of optimal echo images. During exercise the echo images were acquired approximately 60-90 s into each 3-min stage. If all images were not acquired within the time frame the duration of the exercise stage was extended to acquire those images. Pedal speed was set at 50 r.p.m., and workloads increased by 25 W every 3 min until exhaustion. Peak oxygen consumed (VO 2peak ) was measured from breath-by-breath gas analysis (ParvoMedics).
Echocardiography. Echocardiograms were performed by registered diagnostic cardiac sonographers (GE Vivid I, GE Medical Systems). As previously described from our laboratory, 19 resting standard 2D images, continuous/ pulse wave and spectral tissue Doppler tracings were obtained. During exercise, 2D image of the parasternal long axis view were obtained for LV outflow tract diameter, quickly followed by four-chamber (for cardiac volumes and mitral flow velocities) and five-chamber views (for pulse-and continuous-wave Doppler-flow tracings). CV measurements were performed offline by a single investigator and the intraclass correlation coefficient (40.80) have been previously reported. 19 Diastolic function: In the supine position, diastolic function was assessed by pulse wave Doppler examination of mitral inflow early (E) and late (A) velocities, and their ratio E/A. Tissue Doppler systolic (s'), early (e'), and late (a') diastolic velocities of the lateral mitral annulus were recorded, from which the é/á and E/e' ratios were calculated. End-diastolic pressure was estimated as 11.96+0.596xE/e'. Pulse wave Doppler examination of pulmonary venous flow was used to measure peak systolic (S) velocity, peak anterograde diastolic (D) velocity, and their ratio S/D, which is an estimate of left atrial reservoir function. 20 Arterial-ventricular coupling: Resting and peak exercise arterialventricular coupling was calculated as: (1) arterial-elastance index (EaI = end-systolic pressure/stroke volume) a measure of the net arterial load;
(2) LV end-systolic elastance index (EesI), a measure of LV contractility and chamber performance, was calculated from BP, stroke volume, ejection fraction and pre-ejection and systolic ejection time intervals from LV outflow Doppler, determined by the validated single-beat technique; 10 (3) arterial-ventricular coupling ratio = EaI/EesI. A detailed description of these equations have previously been reported from our laboratory. 19 Scaling for body size Scaling of physiological measures for body size is essential when examining the effects of obesity on physiological parameters. Hemodynamic indices that depend on volume are influenced by body size, and therefore should be normalized to body surface area. Appropriate scaling of CV parameters to body size may represent either ratiometric or allometric scaling. 21, 22 According to previous analyses that examined the normal physiological (only healthy subjects without any CVD and with a BMI between 18-25 kg m −2 ) relationship between body size and Ea/Ees and found that Ea and Ees were linearly related to body surface area. 21 Thus, Ea and Ees were indexed (noted by I, that is, EesI and EaI) ratiometrically to body surface area, whereas their ratio Ea/Ees is a dimensionless parameter. Further, the ratiometric adjustment of VO 2peak to body weight was found to be acceptable in adults. 23 
Statistical analysis
Measurements of CV function were performed offline by a single investigator who was blinded to group allocation. The intraclass correlation coefficient (ICC) and coefficient of variations for all echocardiographic variables were derived in a subset of subjects (n = [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . At rest, the ICC and the coefficient of variation for all variables, collected on two separate days, was 40.80 or between 7-12%, respectively. In particular, cfPWV (coefficient of variation = 3% and ICC = 0.98), cIMT (coefficient of variation = 3% and ICC = 0.96), AP (coefficient of variation = 6% and ICC = 0.99), and AGI (coefficient of variation = 6% and ICC = 0.97). Similar results were obtained for echocardographic variables evaluated during peak exercise with all variables having an ICC40.80 and coefficient of variation between 7-12% with the exception of the arterial-ventricular coupling ratio (ICC = 0.63).
We examined the relationship between obesity and CV function in two forms: (1) by assigning individuals into BMI and WC groups; and (2) through examination of BMI and WC as continuous functions in multilinear regression models. BMI groups were defined as normal 18-24.99 kg m −2 ; overweight 25.0-29.9 kg m −2 ; and obese ⩾ 30 kg m −2 . 24 WC groups were defined as non-risk (group 1: maleo102, femaleo 88) and at-risk (group 2: male ⩾ 102, female ⩾ 88). Differences between BMI groups were analyzed by a one-way analysis of variance, or Kruskal-Wallis Test with a post hoc test, whereas comparisons between WC groups were analyzed by an independent t-test or Mann-Whitney test. The changes from rest to peak exercise in EaI, EesI, and EaI/EesI were examined by a time (rest to peak exercise) by group (BMI or WC) interaction evaluated using a two-way repeated-measures analysis of variance with Tukey's post hoc test.
Stepwise backwards linear regression models (removal criteria was set at a Po0.1) were used to determine whether BMI, WC or %BF was a predictor of the CV parameters after adjusting for confounding risk factors, such as age, sex, fasting glucose, insulin (or HOMA-IR), Tg (or HDL or the Tg/HDL ratio) and hypertension (HTN) status. HTN was defined as a SBP 4140 mm Hg or DBP 490 mm Hg, or subject's self-reported history of HTN, or anti-HTN medications. We also added to the final backward elimination models a BMI (WC or %BF) by sex interaction term to establish if sex differences existed in the relationship between obesity and CV parameters. As, BMI, WC and %BF were highly correlated, these variables were examined separately in the regression models. Data are presented as means ± s.e.m. and P ⩽ 0.05 was required for significance. All analyses were performed using SPSS version 20 (SPSS Inc., Chicago, IL, USA). Table 1 , obese subjects were characterized by a higher BMI or WC, higher Tg, glucose (for BMI only), insulin, Tg/HDL and lower HDL concentrations. Hypertension was present in 30% of subjects, with 84% of those subjects on HTN medications. Furthermore, obese subjects had a greater prevalence of HTN (54 vs 3%) and HTN medications (43 vs 3%) vs normal weight individuals (Table 1 ). However, similar ejection fractions were evident between obesity groups.
RESULTS
As evident in
Relationship between obesity, blood pressure, and arterial structure/function BMI group comparisons indicated that obese subjects had increased BP (brachial and central), cIMT, cCSA, CDd and PWVcf vs normal or overweight subjects (Table 1) . However, AGI did not differ in obese compared with normal (23+3%) and overweight (23+3%) subjects. Similar findings were also evident when comparing BP and arterial parameters between WC groups (Table 1 and Supplementary Table 1 ).
As obese subjects had a greater prevalence of CV risk factors, which may be responsible for the physiological differences, we examined the relationship between BMI (as a continuous variable) and markers of arterial structure and function after adjusting for CV risk factors. In stepwise backward elimination models, BMI remained a predictor for cCSA (β = 0.39, P o 0.01), CDd (β = 0.40, Po 0.01), bSBP (β = 0.32, Po 0.01), MAP (β = 0.28, P o0.05), cSBP (β = 0.22, P o0.05), AGI (β = − 0.26 P o 0.01) and AGI@HR75 (β = − 0.23, Po 0.01). The introduction of CV risk factors removed BMI as a predictor of bPP, cPP, PWVcf and cIMT leaving only age, Tg and HTN status in the final models ( Table 2 ). A similar relationship was found between WC (as a continuous variable) and cIMT, cCSA, CDd, cfPWV, AGI and AGI@HR75 ( Table 2) . Although WC remained a predictor of bSBP after adding CV risk factors to the regression models, the relationship between WC and cSBP was no longer evident; rather age and HTN status were the main predictors ( Table 2) . As for %BF, the only differences noted Obesity and cardiovascular dysfunction compared with BMI or WC, was that %BF was not a predictor of AP, AGI or AGI@HR75. With the exception of AGI and AGI@HR75, no sex-by-BMI (or WC) interactions were evident in the final models. A significant sex-by-WC interaction term was noted for AGI and AGI@HR75 whereby AGI (or AGI@HR75) decreased in women but increased in men with increasing WC. Further, no sexby-%BF interactions were noted. When HOMA-IR, HDL or the Tg/ HDL ratio replaced glucose, insulin or Tg in the backward elimination models, the main findings were not changed (Supplementary Table 3 ).
Relationship between obesity and resting left ventricular diastolic function.
When comparing BMI groups, only the A-wave velocity was higher in obese vs normal weight subjects (16%, P o 0.05), whereas the E-wave velocity was higher in overweight vs obese subjects (14%, P o0.05; Figure 2 ). In contrast, WC group 2 had higher (P o0.05) values of A-wave, E/e', EDP, S/D, and lower values of e', and e'/a' vs WC group 1 (Figure 1 , and Supplementary Table 2 ). When examining the backward elimination regression models adjusting for the CV risk factors, BMI predicted only A-wave velocity (β = 0.56, P o0.01), S/D (β = 0.23, P = 0.03), and e'/a' (β = − 0.21, P = 0.04); whereas for E-wave, E/A ratio, e', E/e' and EDP, age was the dominate predictor, not BMI (Table 3 ). In contrast, WC remained a predictor of A-wave (β = 0.21, P = 0.03), E/e' (β = 0.28, Po0.01), EDP (β = 0.28, Po0.01), S/D (β = 0.24, P = 0.03) and e'/a' (β = − 0.27, Po0.01) in the regression models (Table 3 ). Of note, %BF provided similar findings to that between WC and diastolic function. When HOMA-IR, HDL or the Tg/HDL ratio replaced Tg in the regression models, minor differences were found, which again did not alter the relationships (Supplementary Table 3 ). The only differences noted were that HOMA-IR and age was associated with e' in the WC models, whereas in the BMI models, HOMA-IR, along with age, was associated with e' and E/e'.
Relationship between obesity and resting and peak exercise arterial-ventricular coupling and aerobic capacity. At rest, both EaI (P o0.05) and EesI (P = 0.06) were reduced in obese compared with normal weight subjects (19-22%), and EaI was lower in obese vs overweight (23%, P o 0.05) subjects ( Figure 2 ). As such, the EaI/EesI ratio did not differ between BMI groups at rest (Figure 2) . At peak exercise, obese subjects also had a reduced (P o0.05) EaI compared with normal (27%) and overweight (23%) subjects. Similarly, obese subjects had a reduced peak EesI compared with normal weight subjects (39%, P o0.05), and the overweight subjects had a reduced peak EesI compared with normal weight subjects (28%, P o 0.05). No differences were found between obese and overweight subjects for peak EesI. As such peak EaI/EesI did not differ by BMI group. Obese subjects also had a reduced VO 2peak compared with normal weight subjects (16.5 ± 0.7 vs 23.3 ± 1.2 ml kg − 1 per min, P o0.05) but not the overweight subjects (16.5 ± 0.7 vs 19.9 ± 1.5 ml kg − 1 per min, P40.05). A similar story was found when comparing WC groups for both resting and peak exercise, EaI, EesI, EaI/EesI and VO 2peak (Supplementary Table 2 ). A significant group (BMI categories) by time (rest vs peak Ex) interaction was found for EaI, and EesI, whereby obese subjects demonstrated a blunted increase in EaI and EesI during exercise ( Figure 2 ). Overweight subjects also had a blunted increase in EesI during exercise compared with normal weight subjects. However, the group by time interaction for EaI/EesI did not reach statistical significance (P = 0.06). As for the relationship between WC and arterialventricular coupling, a significant group by time interaction was found for EesI, but not for EaI or EaI/EesI (Figure 2 ).
In the regression models, BMI remained a significant predictor of resting EaI (β = − 0.32, Po 0.01), and EesI (β = − 0.36, P o0.01) but not for resting EaI/EesI. Similarly, at peak exercise, BMI Table 4 ). When BMI was replaced with WC, a similar story was evident in that at rest and peak exercise WC remained in the backward elimination models for both EaI and EesI, and VO 2peak , but not for resting or peak exercise EaI/EesI. However, unlike BMI or WC, no relationship existed between resting and peak exercise EaI and EesI and %BF. For peak EesI, this was attributed, in part, to a sex-by-%BF interaction (P = 0.058), whereby EesIpeak decreased with increasing %BF, but in men there was no relationship between peak EesI and %BF. A significant sex-by-WC interaction was also noted for peak EesI whereby slope of the decrease in peak EesI was stronger in women than men. Of note, no sex-by-BMI interactions were noted. When HOMA-IR, HDL or the Tg/HDL ratio replaced Tg in the backward elimination models, minor differences were found, which did not interfere with how WC or BMI predicted arterial-ventricular coupling or VO 2peak (Supplementary Table 3 ).
DISCUSSION
A novel aspect of the present study is the simultaneous measurement of a number of anthropometric and CV (at rest and peak exercise) related indices in obese individuals without T2DM and overt CV disease. Our data suggests that obesity is reflected by carotid remodeling, increased central and brachial pressures, reduced resting LV diastolic function, along with decreased peak exercise LV contractility and aerobic capacity. Furthermore, WC may represent a better predictor of diastolic function than BMI. Importantly, these associations were Obesity, blood pressures and arterial structure/function HTN is approximately twice as prevalent in obese compared with normal weight individuals. 25 In addition, body fat distribution is thought to be an important contributor to the association between obesity and HTN. 26, 27 As such, bSBP has been shown to increase with increasing BMI and WC. [28] [29] [30] However, the relationship between BMI, WC, %BF and central pressures in individuals without overt CV disease or T2DM has not been well examined. In the present study, overall adiposity rather than central adiposity has a significant role in increasing both bSBP and cSBP. Our results confirm and expand on the findings by Kolade et al. 29 who identified a differential association between bSBP and cSBP with WC/hip ratio. It has been postulated 29 that the increased HR, cardiac output and peripheral vasodilatation identified in 'healthy' obese subjects 31, 32 may explain the differences between bSBP and cSBP and body size. Our data suggests that cardiac output and peripheral resistance, but not HR, have a role in the differential association between bSBP and cSBP and body size. Although, arterial stiffness and cIMT has been shown to be greater in obese individuals, 4,33 this increased arterial remodeling likely reflects the co-occurrence of CV risk factors with obesity, specifically age and HTN; whereby at higher distending pressures, the force on the arterial wall is transferred to the stiffer collagen limiting distention. This suggests that PWVcf and cIMT may not be a pathophysiological consequence of obesity per se, but rather a reflection of the co-occurrence of CV risk factors in particular age, HTN and Tg.
As previously reported, 29, 34 we found an inverse association with AP and AGI and both BMI and WC, which seems counterintuitive. Of note, this inverse relationship may be sex dependent as AGI increased in men but decreased in women with increasing BMI or WC; however, further research is required to verify this sex difference. A potential mechanism as to why with increasing adiposity AGI is lower could be a reflection of the dilation of the central arteries. In our study, carotid lumen diameter increased with increasing BMI and WC. Similarly, an increase in radial artery diameter and compliance has been reported in obese individuals. 35 Such differences likely act to dampen the pressure amplification resulting in a reduced AGI. Indeed in our study, AP (a measure of the contribution of wave reflections to SBP) was inversely related to BMI and WC. Interestingly, %BF was not related to AP or AGI. Whether, this arterial dilation and compliance is an initial adaptive response and that persistent exposure to an obese state or with the presence of overt CV disease, results in a reversal of this association remains unknown and requires further study.
Resting LV diastolic function LV diastolic function is thought to be a precursor of LV systolic dysfunction and heart failure, [36] [37] [38] and a risk factor for all-cause and CV mortality. 37 This highlights the clinical importance of recognizing the early and/or subclinical differences in diastolic function. Increasing adiposity has been shown to be a predictor of resting LV diastolic function. 8, 39 However, we did not find strong differences between BMI groups for markers of diastolic function. In contrast, a number of markers of diastolic function differed by WC groups, and in the regression models. Although evidence has shown that general adiposity (by BMI) is a strong predictor of diastolic function, 8, 39 this may reflect a greater level of diastolic dysfunction (grade 1 and 2) due to the inclusion of individuals with T2DM and overt CV disease. This would suggest that central adiposity may be more sensitive to identifying the initial differences in diastolic function in individuals without overt CV 
Abbreviations: a' , mitral annular late diastolic velocity; A-wave, peak velocity of the late diastolic mitral flow; BMI, body mass index; D, peak anterograde diastolic velocity; e' , mitral annular early diastolic velocity; EDP, end-diastolic pressure; E-wave, peak velocity of the early diastolic mitral flow; HDL, high density lipoprotein; HTN, hypertension; S, peak systolic velocity; TG, triglycerides; WC, waist circumference. Significance (Sig.) defined as Po0.05.
disease, whereas, BMI may not be a predictor of diastolic dysfunction until after the onset of chronic CV disease. Further, WC seems to be a stronger predictor over BMI of myocardial infarction, ischemic stroke, and for total and CV mortality. 40, 41 Taken together these findings suggest a link between central adiposity and diastolic function as one of the underlying causes of an increased CV mortality risk.
Obesity and arterial-ventricular coupling Arterial-ventricular coupling, and its determinants, are important for CV performance 10 and a predictor of CV mortality. 11 With aging, in individuals with the metabolic syndrome, and in heart failure patients, resting EaI/EesI is maintained around 0.7-1.0 to optimize CV efficiency. 19, 42, 43 Indeed, with increasing BMI (WC or %BF) EaI/EesI remained stable at 0.75-0.82 at the expense of EaI and EesI, which decreased with increasing BMI or WC, but not %BF.
This differs from the findings of Chirinos et al., 21 who suggested that EesI and EaI increase with increasing BMI. However, these findings did not take into account the CV risk factors associated with increasing adiposity. Further, the decrease in EaI, a measure of net arterial load, may be explained, in part, by the lack of association between BMI (or WC) and PWVcf and the reduction in AGI with increasing BMI (or WC). The reduction in resting EesI may reflect a decrease in LV contractile function or simply a compensatory response to ensure that the coupling ratio is maintained within normal limits for optimal CV performance.
To what extent this relationship remains evident after the development of T2DM or overt CV disease with increasing adiposity warrants further examination. During exercise, EaI/EesI decreases due to an acute mismatch between EesI and EaI to optimize CV performance. 10 Although EaI/ EesI decreased during exercise, no differences in peak EaI/EesI were identified with increasing obesity because of a similar Obesity and cardiovascular dysfunction decrease in peak EaI and EesI. We have previously shown that peak EaI/EesI is not maintained in individuals with the metabolic syndrome, 19 in which obesity is a key determinant. This would suggest that the added CV risk factors that determine metabolic syndrome (Tg, glucose, HTN) have a critical role in the decreased peak exercise EaI/EesI. The decrease in peak EesI with increasing adiposity likely reflects a reduction in peak exercise LV contractility, which also corresponded to a decrease in VO 2peak with increasing adiposity.
Measures of obesity
We show that in the most part BMI, WC and %BF provide similar insights into the CV dysfunction noted with obesity, with the exception of LV diastolic function, in which WC and %BF seem to be better predictors. Further, %BF was not associated with some markers of arterial health (AP, AGI) and arterial-ventricular coupling. These differences may reflect how the obesity parameters represent different fat compartments, with BMI representing an estimation of total adiposity, and WC a measure of central visceral adiposity, sub-cutaneous adipose depots (or both). 13, 14 However, BMI has poor sensitivity for calculating %BF, 13 and it does not take into account body fat distribution, which may be more important than total adiposity as a risk factor for CV disease. For example, pericardial and perivascular adipose tissue are not accounted for in these measures of obesity. These fat deposits are associated with impaired arterial and cardiac function, due to their direct effects on the tissue. 44, 45 More direct measures (magnetic resonance imaging or computed tomography) of fat distribution may provide greater insight into the role of site specific fat accumulation.
Obesity is a pro-inflammatory state, 46, 47 and pro-inflammatory cytokines have a role in both CV dysfunction. 48, 49 In particular, it has been postulated that intraabdominal or visceral fat depots have the strongest impact on inflammatory markers, 50 which may, in part, explain the greater associations noted between WC and CV function compared to BMI or %BF. Further, sex differences are noted in the association between adiposity and inflammation in particular the type/location of adiposity. 51, 52 Such differences may account for the sex-by-WC (or BMI) for AGI, and peak exercise EesI (for %BF). Further research is required in this interesting topic.
Limitations
This was a cross-sectional study rather than a prospective study, and therefore we cannot identify causality. We are not able to exclude the influence of CV medications, which may have altered CV associations. However, hypertensive medications were used to identify the prevalence of HTN, which was added into the regression models. Although pressure and flow were not directly measured, but rather estimated from noninvasive surrogates, these have been previously validated against invasive hemodynamic measurements performed at rest. 53, 54 Also, the noninvasive measurement of EesI has not been validated during exercise. Given the small number of men in our study, the sex differences noted should be regarded as preliminary, until we or others can obtain data on a larger population of male subjects. Finally, differences in the association between BMI, WC and %BF and CV function, may be due to the degree of inflammation that may differ depending on the pattern of fat distribution in the body. In conclusion, this study demonstrates that individuals with increasing obesity without T2DM and overt CV disease, display evidence of arterial remodeling, reduced resting LV diastolic and systolic function, along with an impaired peak exercise LV contractile function and exercise intolerance. Further with the exception of cSBP and LV diastolic function, both increasing BMI and WC (as markers of obesity) display similar levels of CV dysfunction.
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